Non-Surgical Treatments of Trigeminal Neuralgia from the Perspective of a Pain Physician: A Narrative Review

Trigeminal neuralgia (TN) is a unilateral disorder characterized by electric shock-like pain, abrupt onset and termination, and limited to one or more branches of the trigeminal nerve. Various therapeutic modalities for TN have been introduced. We searched for literature indexed in PubMed, Medline, and the National Library of Medicine and reviewed all relevant articles on non-surgical treatments for TN. Published studies were reviewed with no restrictions on date; reviews, clinical trials, animal studies, retrospective studies, and cases were included. Carbamazepine and oxcarbazepine are the recommended first-line pharmacotherapies. Interventional treatments should be considered when pharmacotherapy is insufficient or withdrawn because of adverse effects.

[1]  Xin Zhao,et al.  The efficacy and safety of gabapentin vs. carbamazepine in patients with primary trigeminal neuralgia: A systematic review and meta-analysis , 2023, Frontiers in Neurology.

[2]  Ji Hoon Park,et al.  Fluoroscopic Analysis of Cannula Tip Location During Radiofrequency Thermocoagulation of the Trigeminal Ganglion. , 2023, Pain Physician.

[3]  F. Luo,et al.  Lidocaine aerosol sprayed on oral and/or nasal mucosa for the rescue of acute trigeminal neuralgia exacerbations: A retrospective study , 2023, Cephalalgia : an international journal of headache.

[4]  J. Sweet,et al.  Current Applications of Ablative Therapies for Trigeminal Neuralgia. , 2023, Neurosurgery clinics of North America.

[5]  Jonathan Quinonez,et al.  The Role of Radiofrequency Ablation in the Treatment of Trigeminal Neuralgia: A Narrative Review , 2023, Cureus.

[6]  Danyang Liu,et al.  Radiofrequency Therapies for Trigeminal Neuralgia: A Systematic Review and Updated Meta-analysis. , 2022, Pain physician.

[7]  A. Perry,et al.  Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases , 2022, Dentistry journal.

[8]  A. Ghaddaf,et al.  Radiofrequency thermoablation of the peripheral branches of trigeminal nerve versus the Gasserian ganglion for treating idiopathic trigeminal neuralgia: A systematic review and meta-analysis , 2022, Journal of Clinical Neuroscience.

[9]  F. Luo,et al.  Effect of CT-Guided Gasserian Ganglion Block with Local Anesthetics and Steroids on Acute/Subacute Zoster-Related Trigeminal Neuralgia: A Multicenter Retrospective Study , 2022, Journal of pain research.

[10]  R. Jena,et al.  Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia , 2022, Cureus.

[11]  Mayank Gupta,et al.  Cervical Spinal Cord Stimulation for Trigeminal Neuralgia: a Narrative Review , 2022, Current Pain and Headache Reports.

[12]  Bing Huang,et al.  Anatomy of the Trigeminal Nerve and Its Clinical Significance Via Fusion of Computed Tomography and Magnetic Resonance Imagery. , 2022, Pain physician.

[13]  X. Bai,et al.  Stem cells from human exfoliated deciduous teeth attenuate trigeminal neuralgia in rats by inhibiting endoplasmic reticulum stress , 2021, The Korean journal of pain.

[14]  Christopher M. Jackson,et al.  Trigeminal Neuralgia: Current Approaches and Emerging Interventions , 2021, Journal of pain research.

[15]  K. Okura,et al.  Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model , 2021, Toxins.

[16]  Kazuya Yoshida.  Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia , 2021, Toxins.

[17]  M. Matharu,et al.  Trigeminal neuralgia: a practical guide , 2021, Practical Neurology.

[18]  B. Romito,et al.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review , 2021, SAGE open medicine.

[19]  R. Benoliel,et al.  The changing face of trigeminal neuralgia—A narrative review , 2021, Headache.

[20]  P. McDonald,et al.  GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators. , 2021, Current topics in behavioral neurosciences.

[21]  Jiali Yang,et al.  Efficacy and safety of radiofrequency in the treatment of trigeminal neuralgia: a systematic review and meta-analysis , 2021, Acta Neurologica Belgica.

[22]  Jeongsoon Kim,et al.  Diplopia After Maxillary Nerve Block Through the Lateral Infrazygomatic Approach: A Case Report and Literature Review , 2021, Journal of pain research.

[23]  T. Nurmikko,et al.  Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia , 2020, The Lancet Neurology.

[24]  G. Juodzbalys,et al.  The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review , 2020, Journal of oral & maxillofacial research.

[25]  C. Lindsley,et al.  Classics in Chemical Neuroscience: Baclofen. , 2020, ACS chemical neuroscience.

[26]  Kazuya Yoshida.  Sphenopalatine Ganglion Block with Botulinum Neurotoxin for Treating Trigeminal Neuralgia Using CAD/CAM-Derived Injection Guide. , 2020, Journal of oral & facial pain and headache.

[27]  Bing Huang,et al.  Effects of Supraorbital Foramen Variations on the Treatment Efficacy of Radiofrequency Therapy for V1 Trigeminal Neuralgia: A Retrospective Study , 2020, Pain research & management.

[28]  A. Nader,et al.  Technical considerations for approaches to the ultrasound-guided maxillary nerve block via the pterygopalatine fossa: a literature review , 2020, Regional Anesthesia & Pain Medicine.

[29]  D. Moore,et al.  A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia. , 2019, British journal of anaesthesia.

[30]  M. Obermann.  Recent advances in understanding/managing trigeminal neuralgia , 2019, F1000Research.

[31]  T. Nurmikko,et al.  European Academy of Neurology guideline on trigeminal neuralgia , 2019, European journal of neurology.

[32]  R. Tolba,et al.  Sphenopalatine Ganglion Block and Radiofrequency Ablation: Technical Notes and Efficacy , 2019, Ochsner Journal.

[33]  N. Singla,et al.  Radiofrequency Thermoablation of the Gasserian Ganglion Versus the Peripheral Branches of the Trigeminal Nerve for Treatment of Trigeminal Neuralgia: A Randomized, Control Trial. , 2019, Pain physician.

[34]  A. Truini,et al.  Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options , 2019, The Journal of Headache and Pain.

[35]  Justin S. Chung,et al.  Urgent care peripheral nerve blocks for refractory trigeminal neuralgia , 2018, The American journal of emergency medicine.

[36]  G. Cruccu,et al.  Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia , 2018, Drugs.

[37]  E. Mariano,et al.  Designing the ideal perioperative pain management plan starts with multimodal analgesia , 2018, Korean journal of anesthesiology.

[38]  A. Allam,et al.  Ultrasound-Guided Intervention for Treatment of Trigeminal Neuralgia: An Updated Review of Anatomy and Techniques , 2018, Pain research & management.

[39]  Sanjeev Kumar,et al.  Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review , 2017, The Journal of Headache and Pain.

[40]  Muke Zhou,et al.  Oxcarbazepine for neuropathic pain. , 2017, The Cochrane database of systematic reviews.

[41]  Fangyu Yang,et al.  Efficacy of 8 Different Drug Treatments for Patients With Trigeminal Neuralgia: A Network Meta-analysis , 2017, The Clinical journal of pain.

[42]  A. Elawamy,et al.  Effects of Pulsed Versus Conventional Versus Combined Radiofrequency for the Treatment of Trigeminal Neuralgia: A Prospective Study. , 2017, Pain physician.

[43]  M. Taşdemir,et al.  Botulinum toxin in the treatment of trigeminal neuralgia , 2017, Medicine.

[44]  Junghyun Park,et al.  Botulinum Toxin for the Treatment of Neuropathic Pain , 2017, Toxins.

[45]  M. Montaudon,et al.  Anatomical landmarks for maxillary nerve block in the pterygopalatine fossa: A radiological study. , 2017, Journal of Stomatology Oral and Maxillofacial Surgery.

[46]  K. Han,et al.  Trigeminal nerve block with alcohol for medically intractable classic trigeminal neuralgia: long-term clinical effectiveness on pain , 2017, International journal of medical sciences.

[47]  J. Lindh,et al.  The effect of carbamazepine on warfarin anticoagulation: a register‐based nationwide cohort study involving the Swedish population , 2016, Journal of thrombosis and haemostasis : JTH.

[48]  Eun-Ji Choi,et al.  Neural Ablation and Regeneration in Pain Practice , 2016, The Korean journal of pain.

[49]  Khalid W. Al-quliti.  Update on neuropathic pain treatment for trigeminal neuralgia , 2015, Neurosciences.

[50]  Haifeng Zhang,et al.  Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial , 2014, The Journal of Headache and Pain.

[51]  Hai-Feng Zhang,et al.  Therapeutic effect of Botulinum toxin-A in 88 patients with Trigeminal Neuralgia with 14-month follow-up , 2014, The Journal of Headache and Pain.

[52]  E. Kalso,et al.  Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. , 2014, The Cochrane database of systematic reviews.

[53]  A. Blitzer,et al.  A new treatment paradigm for trigeminal neuralgia using botulinum toxin type a , 2014, The Laryngoscope.

[54]  Muke Zhou,et al.  Non-antiepileptic drugs for trigeminal neuralgia. , 2013, The Cochrane database of systematic reviews.

[55]  Hai-Feng Zhang,et al.  Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial , 2012, Cephalalgia.

[56]  S. Shaikh,et al.  Lamotrigine for trigeminal neuralgia: Efficacy and safety in comparison with carbamazepine☆, ☆☆ , 2011, Journal of the Chinese Medical Association : JCMA.

[57]  T. Nurmikko,et al.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.

[58]  M. Nguyen,et al.  Pulsed Radiofrequency V2 Treatment and Intranasal Sphenopalatine Ganglion Block: A Combination Therapy for Atypical Trigeminal Neuralgia , 2010, Pain practice : the official journal of World Institute of Pain.

[59]  Howard L McLeod,et al.  Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. , 2008, Pharmacogenomics.

[60]  M. Brainin,et al.  AAN‐EFNS guidelines on trigeminal neuralgia management , 2008, European journal of neurology.

[61]  H. Diener,et al.  Efficacy of Pregabalin in the Treatment of Trigeminal Neuralgia , 2008, Cephalalgia : an international journal of headache.

[62]  S. Silberstein,et al.  An open study of botulinum-A toxin treatment of trigeminal neuralgia , 2005, Neurology.

[63]  R. Alp,et al.  Botulinum Toxin and Intractable Trigeminal Neuralgia , 2005, Clinical neuropharmacology.

[64]  P. Goadsby.  Pathophysiology of cluster headache: a trigeminal autonomic cephalgia , 2002, The Lancet Neurology.

[65]  S. Schachter.  Oxcarbazepine: current status and clinical applications. , 1999, Expert opinion on investigational drugs.

[66]  Keiji Ishizaki,et al.  The long lasting effects of peripheral nerve blocks for trigeminal neuralgia using a high concentration of tetracaine dissolved in bupivacaine , 1999, Pain.

[67]  B. van der Dijs,et al.  Pimozide therapy for trigeminal neuralgia. , 1989, Archives of neurology.

[68]  T. Lyberg,et al.  Tizanidine in the Management of Trigeminal Neuralgia , 1986, Cephalalgia : an international journal of headache.

[69]  S. Sanli,et al.  [Sphenopalatine ganglion pulsed radiofrequency treatment in patients suffering from chronic face and head pain]. , 2016, Revista brasileira de anestesiologia.

[70]  M. H. Motamedi,et al.  Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[71]  M. Tobe,et al.  Technical communication: percutaneous radiofrequency mandibular nerve rhizotomy guided by high-speed real-time computed tomography fluoroscopy. , 2010, Anesthesia and analgesia.

[72]  G. Borodic,et al.  The use of botulinum toxin for the treatment of chronic facial pain. , 2002, The journal of pain : official journal of the American Pain Society.